PROF (Profound Medical Corp.) Stock Financials & Earnings | Market Cap Arena

PROF (Profound Medical Corp.) Stock Financials & Earnings | Market Cap Arena

PROFProfound Medical Corp.

Mkt Cap$167M

Healthcare·Medical - Devices·🇨🇦 Canada·NASDAQ

Revenue (TTM)$16M

Net Income (TTM)$42M

EPS (TTM)-$1.62

Free Cash Flow (TTM)-$38M

Gross Margin70.8%

Op. Margin-256.3%

Net Margin262.9%

FCF Margin-238.5%

P/S Ratio (TTM)10.4x

P/E Ratio (TTM)4.0x

YoY Rev Growth+25.5%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$2M	$1M	-$7M
Q2 23	$2M	$1M	$6M
Q3 23	$2M	$1M	-$7M
Q4 23	$3M	$1M	-$64M
Q1 24	$1M	$866K	-$8M
Q2 24	$2M	$1M	-$8M
Q3 24	$4M	$2M	$12M
Q4 24	$5M	$4M	-$82M
Q1 25	$3M	$2M	-$11M
Q2 25	$2M	$2M	-$14M
Q3 25	$5M	$4M	-$9M
Q4 25	$6M	$4M	-$7M

Valuation

Quarter	P/S	P/E
Q1 23	20.0x	—
Q2 23	21.0x	—
Q3 23	24.3x	—
Q4 23	21.3x	—
Q1 24	22.5x	—
Q2 24	20.8x	—
Q3 24	16.5x	—
Q4 24	13.0x	—
Q1 25	11.9x	—
Q2 25	12.0x	—
Q3 25	10.9x	—
Q4 25	10.4x	4.0x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$6M	-$6M
Q2 23	-$5M	-$5M
Q3 23	-$4M	-$4M
Q4 23	-$7M	-$7M
Q1 24	-$5M	-$5M
Q2 24	-$6M	-$6M
Q3 24	-$7M	-$7M
Q4 24	-$6M	-$6M
Q1 25	-$8M	-$8M
Q2 25	-$14M	-$14M
Q3 25	-$9M	-$9M
Q4 25	-$7M	-$7M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$0
Q2 23	$0
Q3 23	$0
Q4 23	$0
Q1 24	$0
Q2 24	$0
Q3 24	$0
Q4 24	$0
Q1 25	$0
Q2 25	$2
Q3 25	$0
Q4 25	$0

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	+9.1%	+217.5%
Q2 23	-20.2%	-149.7%
Q3 23	-38.5%	+196.8%
Q4 23	+56.4%	-12.8%
Q1 24	-22.6%	+7.0%
Q2 24	+39.4%	+308.4%
Q3 24	+121.6%	-200.4%
Q4 24	+100.1%	+31.2%
Q1 25	+82.1%	+48.0%
Q2 25	-1.0%	+59.0%
Q3 25	+36.6%	+268.7%
Q4 25	+13.3%	-84.6%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$941K	50.6%
Q2 23	$842K	52.6%
Q3 23	$727K	42.1%
Q4 23	$907K	34.1%
Q1 24	$767K	53.3%
Q2 24	$768K	34.4%
Q3 24	$604K	15.8%
Q4 24	$442K	8.3%
Q1 25	$989K	37.7%
Q2 25	$0	0.0%
Q3 25	$0	0.0%
Q4 25	-$4M	-68.1%

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q1 23	$4M	—	—	$4M
Q2 23	$3M	$2M	$2M	—
Q3 23	$3M	$2M	$2M	—
Q4 23	$5M	$8M	$9M	—
Q1 24	$4M	$2M	$2M	—
Q2 24	$4M	—	—	$5M
Q3 24	$6M	$5M	$4M	—
Q4 24	$7M	$12M	$12M	—
Q1 25	$5M	—	—	$8M
Q2 25	$6M	—	—	$9M
Q3 25	$5M	$7M	—	—
Q4 25	$4K	—	—	$7K

Revenue Segments

Quarter	Capital Equipment	Recurring - Non-Capital
Q1 25	$820K	$2M
Q2 25	$650K	$2M
Q3 25	$1M	$4M
Q4 25	$4M	$2M

Revenue by Geography

Quarter	California	Delaware	United States	Canada	Germany
Q1 25	$852K	$226K	$2M	—	—
Q4 25	—	—	$4M	$2M	$465K

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$43M	$0	$43M
Q2 23	$39M	$0	$39M
Q3 23	$33M	$0	$33M
Q4 23	$35M	$0	$35M
Q1 24	$56M	$0	$56M
Q2 24	$47M	$0	$47M
Q3 24	$27M	$0	$27M
Q4 24	$55M	$0	$55M
Q1 25	$46M	$0	$46M
Q2 25	$35M	$0	$35M
Q3 25	$25M	$0	$25M
Q4 25	$82M	$0	$82M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	21M	+0.3%
Q2 23	21M	+1.2%
Q3 23	21M	+1.1%
Q4 23	21M	-0.1%
Q1 24	24M	+11.6%
Q2 24	24M	+2.5%
Q3 24	25M	+0.8%
Q4 24	26M	+4.6%
Q1 25	30M	+16.6%
Q2 25	30M	+0.0%
Q3 25	30M	+0.2%
Q4 25	31M	+2.1%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 20	—	—
FY 21	—	—
FY 22	—	—
FY 23	—	—
FY 24	$1K	8K
FY 25	$2K	8K